TW201215422A - Syringe capable of containing different injectable medicines - Google Patents

Syringe capable of containing different injectable medicines Download PDF

Info

Publication number
TW201215422A
TW201215422A TW99135408A TW99135408A TW201215422A TW 201215422 A TW201215422 A TW 201215422A TW 99135408 A TW99135408 A TW 99135408A TW 99135408 A TW99135408 A TW 99135408A TW 201215422 A TW201215422 A TW 201215422A
Authority
TW
Taiwan
Prior art keywords
top surface
groove
syringe
ring
center
Prior art date
Application number
TW99135408A
Other languages
Chinese (zh)
Inventor
Kuo-Cheng Wu
Original Assignee
Wu Chen Wen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wu Chen Wen filed Critical Wu Chen Wen
Priority to TW99135408A priority Critical patent/TW201215422A/en
Publication of TW201215422A publication Critical patent/TW201215422A/en

Links

Abstract

The present invention provides a syringe capable of containing different injectable medicines, which includes a syringe barrel, a blocking plate, two plungers, a cover plate, and a pushing plate. Through the blocking plate being inserted into a hollow accommodation space of the syringe barrel, the syringe barrel can be divided into two accommodation chambers for filling with two different liquid medicines or powder medicines. When the two different liquid medicines or powder medicines is required to be mixed with each other or dissolved for subcutaneous injection, the blocking plate can be removed from the syringe barrel so as to mix medicines for liquid injection. Therefore, an injection needle and the syringe barrel is no longer required to be utilized as tools for mixing medicines, so as to prevent the medicines from being contaminated in an entire sterile process and prevent medical staffs from needlestick injuries.

Description

201215422 六、發明說明: 【發明所屬之技術領域】 本發明是關於—種「可容置不同注射藥劑之注 • #器」,尤指-種可將兩種以上不同之注射用藥劑, • 直接充填入注射筒內並保持不會相互混合之暫時性 分離狀態,當有需要混合施以皮下注射治療時,只 需將注射筒内的隔離片抽出注射筒外,便可同步完 成注射筒內不同藥劑的相互混合,而具有避免藥劑 被污染的全程無菌操作功效,以及免除醫護人員被 注射針扎傷之風險。 【先前技術】 如第一圖所示,目前所有使用於皮下注射之液 態處方藥劑R,均是被密封充填於注射藥劑瓶i内, 當需要施以皮下注射治療時,先將注射針3經由瓶 I 口塞2插入注射藥劑瓶丨内,再抽取其内部之液態 處方藥劑R至注射筒4中,最後把注射針3抽離注 射藥劑瓶1外,便可拿來對患者進行皮下注射。 以曰本武田藥品公司(Takeda Pharmaceutical Company Limited)所生產製造—種治療乳癌及前列 腺癌之皮下注射藥劑(化學名為5-ox〇-pr〇iyI_ histidyl-tryptophyl-seryl-tyrosyl-D-leucyl-leucyl-ar ginyl-N-ethyl-proUnamidemonoacetate)為例,其外201215422 VI. Description of the Invention: [Technical Field of the Invention] The present invention relates to a "can be used to accommodate different injections of drugs", and in particular, to use two or more different injection drugs, Filling into the syringe and maintaining a temporary separation state that does not mix with each other. When it is necessary to mix and apply subcutaneous injection treatment, it is only necessary to take out the spacer in the syringe out of the syringe, and the different syringes can be simultaneously completed. The medicaments are mixed with each other, and have the full-stage aseptic operation effect of avoiding the contamination of the medicament, and the risk of the medical staff being injured by the injection needle. [Prior Art] As shown in the first figure, all liquid prescription drugs R currently used for subcutaneous injection are sealed and filled in the injection drug bottle i. When subcutaneous injection treatment is required, the injection needle 3 is first passed through The bottle I plug 2 is inserted into the injection bottle, and the liquid prescription drug R inside is extracted into the syringe 4. Finally, the needle 3 is pulled out of the injection bottle 1 and the patient can be subcutaneously injected. Subcutaneous injection of a drug for the treatment of breast cancer and prostate cancer, manufactured by Takeda Pharmaceutical Company Limited (chemical name: 5-ox〇-pr〇iyI_histidyl-tryptophyl-seryl-tyrosyl-D-leucyl- Leucyl-ar ginyl-N-ethyl-proUnamidemonoacetate), for example, outside

201215422 觀是呈略帶黃白色的粉末,在經由合格醫師開立處 万箋後,探用注射方式來施打於乳癌或前列腺癌之 患者身上,而在施打注射前必須先將該粉末狀的 Leupf〇relin acetate藥劑溶解於藥劑溶 又 丹籍由 注射針筒來進行皮下注射,因此,目前販售之包裝 上除將粉末狀的Leuprorenn acetate藥劑充填密封於 注射藥劑瓶!外,另外會附上—瓶充填有藥劑溶液 Ri之玻璃瓶G,其混合操作之步騾如第二圖至第六 圖所示,a•首先,以手指捏持破璃瓶g的頸部並施2 給予折斷(如第二圖所示),b.再將注射針3伸入破 璃瓶G内抽取其内部充填之藥劑溶液幻至注射筒4 中(如第三圖所示)’ C.接著,將注射針3穿透瓶口 塞2後插入注射藥劑瓶1內’並將注射筒4内的藥 劑溶液R1全數推入注射藥劑瓶!内’使其與粉末狀 LeUpr〇relin acetate藥劑s進行溶解(如第四圖所 示),d.隨後把注射針3抽離注射藥劑瓶i外,再搖 晃震動注射藥劑瓶1數次,使其充分混合達成完全 溶解成為液態注射用藥冑M1 (如第五圖所示),e. 最後,再-次將注㈣3插入該注射藥劑瓶i内來 抽取該液態注射用藥劑Mlt (如第六圖所示),便 可拿來對患者進行皮下注射。 201215422 由上述操作過程中可私担 证發現,在步驟b&e中均 需藉由注射針3及注舢何a + 汉迁射筒4來做為混合溶解藥劑作 業之工具’因此,伴隨荽包并Eft# 汗隨者母位醫護人員之專注力及 熟練度的不同,均會存在潑_& k 仔在發生外界異物或細菌侵入 汙染藥劑溶液粉末狀藥劑 S之風險’若稍有不慎即無法達成全程無菌操作之要201215422 The view is a slightly yellowish-white powder. After being opened by a qualified physician, the injection method is used to apply to patients with breast cancer or prostate cancer, and the powder must be applied before the injection. The Leupf〇relin acetate agent is dissolved in the drug and the Dan is injected subcutaneously by the syringe. Therefore, the powdered Leuprorenn acetate is filled and sealed in the injection bottle on the package currently sold! In addition, the glass bottle G filled with the drug solution Ri is attached, and the mixing operation steps are as shown in the second to sixth figures. a• First, the neck of the glass bottle g is pinched by fingers. And apply 2 to break (as shown in the second figure), b. Then insert the needle 3 into the glass bottle G and extract the internal filling agent solution into the syringe 4 (as shown in the third figure) C. Next, the injection needle 3 is inserted into the injection bottle 1 after penetrating the bottle stopper 2, and the drug solution R1 in the syringe 4 is pushed all the way into the injection bottle! Internally, it is dissolved with the powdered LeUpr〇relin acetate s (as shown in the fourth figure), d. Then the injection needle 3 is pulled out of the injection bottle i, and then shaken and injected into the drug bottle 1 several times, so that It is fully mixed to achieve complete dissolution into a liquid injectable drug 胄M1 (as shown in the fifth figure), e. Finally, re-injection (4) 3 into the injection drug bottle i to extract the liquid injection drug Mlt (such as the sixth The figure can be used to subcutaneously inject the patient. 201215422 It can be found in the above operation that it can be used as a tool for mixing and dissolving the drug in the step b&e in the step b&e. There is a difference between the concentration and proficiency of the package and the Eft# sweating mother's health care staff. The risk of sputum _& k in the presence of external foreign bodies or bacteria invading the contaminated drug solution powdered drug S is a little bit It is impossible to achieve the full aseptic operation

求,此外,步騾b、c & e的操作過程中,也可能導 致醫護人員被注射針3扎傷之情形。 再者,該充填有藥劑溶液R1之坡璃瓶〇與充填 有粉末狀Leuprorelin acetate藥劑s之注射藥劑瓶 1,其兩者的製造時間並不是在同一時間完成,而是 依照藥廠安排生產期程來製造,故其各自的有效日 期之期限便會不同,因此醫療單位購入庫存後必須 額外管控兩者之有效日期,甚至醫護人員在操作混 合洛解作業前,亦需特別目視辨識是否均在有效日 期内,否則該次施以皮下注射之液態注射用藥劑M】 便會因超過有效期限而無法產生療效。 又如第七圖至第十圖所示,某些治療其他疾病 用之混合型注射用藥劑,則是將第一液體藥劑R2及 第二液體藥劑R3分別充填入兩個注射藥劑瓶〗a及 lb内’其在施以皮下注射前之混合操作步驟為3先 201215422 將注射針3插入充填有第_液體藥劑R2之㈣㈣ 瓶1a內’並將該第-液體藥劑R2全數吸入注射筒4 後,_抽離注射藥劑瓶u夕卜(如第七圖所示), . b.接著’將注射針3再插入另-注射藥劑瓶lb內, , f把庄射筒4內的第-液體藥劑R2全數推入注射藥 劑瓶lb後’又抽離該注射藥劑瓶ib外(如第八圖 所示)’ 經震動搖晃注射藥劑瓶lb數次後,使該第 Φ 一液體藥劑R2與第二液體藥劑R3在該注射藥劑瓶 1 b內進行充分混合成為液態注射用藥劑μ 2 (如第九 圖所不)’ c_最後,再次以注射針3插入該注射藥劑 瓶1 b内來抽取液態注射用藥劑M2後(如第十圖所 示)’便可拿來對患者進行皮下注射。 同樣地’前述操作過程中仍是利用注射針3及 注射筒4來做為混合兩種液體藥劑之工具,故仍會 鲁發生因醫護人員專注力及熟練度的不同,所導致醫 - 護人員可能被注射針扎傷之情形,以及存在注射針3 • 不慎觸及外界異物或被細菌附著導致汙染第一液體 藥劑R2或第二液體藥劑R3之風險;再者,該第一 液體藥劑R2及第二液體藥劑R3出廠的包裝方式, 均是探單獨被充填入各自的注射藥劑瓶la及ib 內’故醫療單位購入時必須被迫支付兩個注射藥劑In addition, during the operation of steps b, c & e, it may also cause the medical staff to be injured by the injection needle 3. Furthermore, the slab bottle filled with the drug solution R1 and the injection bottle 1 filled with the powdered Leuprorelin acetate s are not manufactured at the same time, but are arranged according to the manufacturer's production period. Cheng Lai is manufactured, so the period of their respective effective dates will be different. Therefore, medical institutions must additionally control the effective date of the two after purchasing the stock. Even the medical staff must visually identify whether they are all in the operation before the mixed operation. Within the effective date, otherwise the liquid injection drug M, which is administered subcutaneously, will not be effective due to the expiration of the expiration date. As shown in the seventh to tenth drawings, in some mixed injection drugs for treating other diseases, the first liquid medicine R2 and the second liquid medicine R3 are respectively filled into two injection medicine bottles 〖a and In the lb, the mixing operation step before the subcutaneous injection is 3 first 201215422. The injection needle 3 is inserted into the (four) (four) bottle 1a filled with the liquid medicament R2, and the first liquid medicament R2 is sucked into the syringe 4 , _ draw away from the injection bottle u (as shown in the seventh figure), . b. Then 'insert the injection needle 3 into the other injection bottle lb, f, the first liquid in the Z-ray After the drug R2 is pushed into the injection bottle lb, it is pulled out of the injection bottle ib (as shown in the eighth figure). After shaking the injection bottle lb several times by shaking, the Φ-liquid reagent R2 and the first The two liquid medicines R3 are thoroughly mixed in the injection medicine bottle 1b to form the liquid injection medicine μ2 (as shown in the ninth figure). c_ Finally, the injection needle 3 is again inserted into the injection medicine bottle 1b to extract After the liquid injection agent M2 (as shown in the tenth figure), it can be used to treat the patient. The next injection. Similarly, in the foregoing operation, the injection needle 3 and the syringe 4 are still used as a tool for mixing two kinds of liquid medicaments, so that the medical staff will be caused by the difference in concentration and proficiency of the medical staff. The possibility of being injured by the injection needle, and the risk of contamination of the first liquid medicament R2 or the second liquid medicament R3 by the injection needle 3 • inadvertently touching foreign matter or adhering to the bacteria; further, the first liquid medicament R2 and The second liquid medicine R3 is packaged in a manner that is separately filled into the respective injection medicine bottles la and ib. Therefore, the medical unit must be forced to pay two injection medicines when purchasing the medical unit.

[SI 6 201215422 瓶la及lb的費用,以每日每年全球使用量來加總 計算,其總支出之費用將會是非常龐大,此外,使 用後所產生廢棄注射藥劑瓶的數量也會形成環保上 的額外負擔。 綠是’ ★卩何解決上述習知各項缺失即為刻不容 緩之事’本發明人有鑑於此乃積極進行研究並終於 完成本發明。 【發明内容】 本發明之主要目的是在提供一種「可容置不同 注射藥劑之注射器」,其包括—注射筒、—阻隔板、 兩活塞塊、—封蓋板及_推進板;藉由阻隔板插入 注射筒的中空容置室内,可間隔出二個容置室來提 供充填兩種不同液體藥劑或粉末狀藥劑,並使其處 於不會發生相互混合之暫時性分離狀態,當需要將 兩種不同液體藥劑或粉末狀藥劑進行相互混合或溶 解來施以皮下注射時,只需將阻隔板朝注射筒外抽 離移位後,即可完成皮下注射用之液態注射用藥劑 的混合作業,其操作過程中不需使用注射針及注射 筒來做為混合藥劑之工具,除可達成全程無菌操作 要求而避免藥劑被污染外,更可免除醫護人員被注 射針扎傷之風險。 201215422 本發明之另—目的係在提供_種「㈣ 注射藥劑之注射器」,其利用注射筒內來作為 種以上之不同液體藥劑或粉末狀藥劑,因此 注射藥劑瓶的使用數量及其成本的支出,除能 對環保上的負擔外,更可在蔣 史】在將阻1½板朝注射筒 離移位後’即直接作為皮下注射施打之用,大 少對患者施打治療程序上的時間耗損,同步地 者也縮短施打注射的等待時間,並有利於病情 速受到藥劑之治療等優點。 【實施方式】 請參閱第十一圖至第二十圖所示,係本發步 容置不同注射藥劑之注射器」之第一實施例, 括: —注射筒10,係為透明中空圓筒體,具有 部面11、一底部面12及一侧端面13,該頂部, 設具成封閉面,該底部面12設具成開口狀,且 部面11與底部面12之間由該側端面13圈圍連 一體,並在內部形成有一中空容置室如第 圖所示)’其中’該頂部面11的中央向外凸設 針頭座I5,並於針頭座15的中央再貫穿有一 151’且該流道151與中空容置室14相互貫通 於底部面12上朝側端面13方向外擴形成有一 :不同 丨填兩 ’減少 減少 外抽 幅減 使患 更快 1「可 其包 一頂 面I1 該頂 接成 十三 有/ 流道 ,另 固定 201215422 翼板16’並在該固定翼16上穿設有相對稱之兩固 定孔161 (如第十二圖所示); 一阻隔板20 ’係塞置入注射筒丨〇之中空容置室 Μ内的扁平長條體,具有一頂部面2卜—底部面22、 -前侧面23、後側面24及相互平行之兩側邊面25, 該兩侧邊面25之間的間距d2 (如第十八圖所示)與 注射筒1〇之中空容置室14的內緣口徑di (如第十 三圖所示)相等,但該頂部面21與底部面U之間 的距離長度d3(如第十八圖所示)則大於注射筒1〇 之頂部面11與底部面12之間的距離長度d4 (如第 十三圖所示)’其中,該頂部面21中央向外凸設有 -圓球凸塞部26’由該圓球凸塞部26的圓心作為軸 心,再朝底部面22方向延伸後分別在前侧面23與 後側面24上各Λ 右 au rpti π Is 丄合又有一半圓凸柱27,且該兩半圓凸 柱27上又各凹設有—相對稱之凹環槽271,並在該 母凹環槽271的尾端設具成倒圓錐部272,另該底 部面22上凸設有兩對稱之凸鉤卡榫28(如第十九圖 所示); 14內綠0徑dl的 兩活塞i鬼30’為具有相同體積的兩個半圓柱 體’其外周緣面的半徑等於注射冑1〇之中空容置室 具有一頂面31、一底 201215422 面32、一前側面33及一半圓弧後側面w,由該頂 面31中央往底面32方向的前侧面33上,凹設有同 軸心之上半圓凹槽35與下半圓凹槽%,並在該上半 圓凹槽35與下半圓凹槽36之間設有—半圓環凸綠 37,使該上半圓凹槽35與下半圓凹槽“之間形成 相互貫通’又該底面32向外凸設有—固定柱38,且 該固定柱38靠近底面32的上段部外周緣面上,與 半圓弧後側面34的外周緣面上包覆有—防止渗漏之 密封層39 ’其中,該上半圓凹槽35的半徑η與阻 隔板之半圓凸柱27的半徑r2相等,該半圓環凸 緣37的半徑r3則與半圓凸柱27之凹環槽π的半 徑r4相等; 一封蓋板40,其外觀輪廓與注射筒〗〇之固定翼 板16相同,具有—頂而41 、一底面42及一侧邊面 43’該頂面41與麻而、咖 、 、底面42 I間由該侧邊面43圈圍連 接成—體,其中,由顶而 由頂面41中央位置朝底面42貫 穿設有—長條缺口 44,可供阻隔板20穿過’另以該[SI 6 201215422 The cost of bottle la and lb is calculated by adding the total annual global usage. The total cost of the expenditure will be very large. In addition, the amount of discarded injection bottles produced after use will also become environmentally friendly. The extra burden on it. Green is '★ 卩 解决 解决 解决 解决 解决 解决 解决 。 。 。 ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ ’ SUMMARY OF THE INVENTION The main object of the present invention is to provide a "syringe capable of accommodating different injection medicaments", which comprises a syringe, a baffle plate, a two-piston block, a cover plate and a _ pusher plate; The plate is inserted into the hollow accommodating chamber of the syringe, and two accommodating chambers are spaced to provide two different liquid medicaments or powder medicaments, and are placed in a temporary separation state without mutual mixing, when needed When different liquid medicines or powdered medicines are mixed or dissolved to be administered subcutaneously, the mixing operation of the liquid injection medicament for subcutaneous injection can be completed by simply removing the barrier plate from the outside of the syringe. In the operation process, it is not necessary to use the injection needle and the syringe as a tool for mixing medicaments. In addition to achieving the full aseptic operation requirements and avoiding contamination of the medicament, the risk of the medical staff being injured by the injection needle can be eliminated. 201215422 Another object of the present invention is to provide a "(four) syringe for injecting a drug" which utilizes a syringe as a different type of liquid medicament or powdered medicament, and thus the amount of the injected medicament bottle and the cost thereof In addition to the burden on the environment, it can also be used in the case of Jiang Shi] after shifting the block to the syringe, that is, directly as a subcutaneous injection, and the time spent on the treatment of the patient. Loss and synchronization also shorten the waiting time for the injection, and it is beneficial to the treatment of the disease by the drug. [Embodiment] Referring to the eleventh to twentieth figures, the first embodiment of the syringe for accommodating different injections of the present invention includes: - the syringe 10 is a transparent hollow cylinder And having a surface 11 , a bottom surface 12 and a side end surface 13 , the top portion being provided with a closed surface, the bottom surface 12 is provided with an opening shape, and the side surface 11 is between the surface 11 and the bottom surface 12 The circle is integrally formed, and a hollow receiving chamber is formed inside, as shown in the figure), wherein the center of the top surface 11 protrudes outwardly from the needle seat I5, and a 151' is further penetrated in the center of the needle holder 15 The flow passage 151 and the hollow accommodating chamber 14 are mutually penetrated on the bottom surface 12 and are outwardly expanded toward the side end surface 13 to have a different shape: reducing the external suction width and reducing the speed of the first one. I1 is topped into a thirteen/flow channel, and the 201215422 wing 16' is fixed, and two fixed holes 161 are formed on the fixed wing 16 (as shown in FIG. 12); a flat strip that is placed in the hollow accommodation chamber of the syringe, having The top surface 2b - the bottom surface 22, the front side surface 23, the rear side surface 24, and the mutually parallel side surfaces 25, the spacing d2 between the two side surfaces 25 (as shown in Fig. 18) and the syringe The inner edge diameter di of the hollow accommodation chamber 14 (as shown in FIG. 13) is equal, but the distance d3 between the top surface 21 and the bottom surface U (as shown in FIG. 18) is larger than a distance d4 between the top surface 11 and the bottom surface 12 of the syringe 1 (as shown in FIG. 13), wherein the center of the top surface 21 is convexly outwardly-ball-shaped portion 26' The center of the spherical plug portion 26 serves as an axial center, and then extends toward the bottom surface 22, and then the right side au rpti π Is and the second rounded convex column 27 on the front side surface 23 and the rear side surface 24, respectively, and the two semicircles The protrusions 27 are further recessed with a symmetrical groove 271, and an inverted conical portion 272 is disposed at the end of the female recessed ring groove 271, and two symmetrical convex portions are convexly disposed on the bottom surface 22.钩卡榫28 (as shown in Figure 19); 14 inside the green 0 diameter dl of the two pistons i ghost 30' is two semi-cylinders of the same volume 'the radius of the outer peripheral surface is equal to the injection The hollow accommodating chamber has a top surface 31, a bottom 201215422 surface 32, a front side surface 33, and a half arc rear side surface w, which is recessed from the front side surface 33 of the top surface 31 toward the bottom surface 32. There is a concentric upper semicircular groove 35 and a lower semicircular groove %, and a semicircular green 37 is provided between the upper semicircular groove 35 and the lower semicircular groove 36, so that the upper semicircular groove 35 and The lower semicircular grooves are formed to be "intersecting between each other" and the bottom surface 32 is outwardly convexly provided with a fixing post 38, and the fixing post 38 is adjacent to the outer peripheral surface of the upper portion of the bottom surface 32, and the outer circumference of the rear side 34 of the semicircular arc. The edge surface is covered with a sealing layer 39 for preventing leakage. The radius η of the upper semicircular groove 35 is equal to the radius r2 of the semicircular stud 27 of the baffle plate, and the radius r3 of the semicircular flange 37 is It is equal to the radius r4 of the concave ring groove π of the semicircular stud 27; a cover plate 40 having the same outer contour as the fixed wing 16 of the syringe, having a top portion 41, a bottom surface 42 and one side surface 43' The top surface 41 and the hem, coffee, and bottom surface 42 I are connected by the side surface 43 to form a body, wherein the top is topped by the top The central portion of the face 41 is disposed through the strip 32 to the bottom surface 42 for the barrier 20 to pass through.

長條缺口 44中央為圓、 P .....^、’分別在其兩側位置的頂面 41上,再凸設有相對稱的兩半圓固定座45,而由該 兩半圓固定座45的頂面向内又各凹設有1槽46, 可供兩活塞塊3〇之固定 疋在38插入,另相對應於注 m 10 201215422 射筒10中固定翼板16之 上,再凸設有兩固定柱47, 部48外徑略大於該固定翼 孔徑;及 兩固定孔161的頂面41 且孩兩固定柱47的末端 板16之兩固定孔101的 ^ m 〇厶反—, 側邊面S3 ’該頂面51與底面S2 〈間由該侧邊面53 圈圍連接成一體’其中,該頂而 頂面S1相對應於阻隔扳 2〇中底部面22之兩凸夠卡榫的位置處,穿設有 兩卡榫孔54,可供兩凸鉤卡榫以插入卡合固定之用。 續如第二十-圖至第三十圖所示,上述本發明 組合及充填藥液的步騾如下: a. 首先,將阻隔板20的頂面21朝向注射筒1〇 的底面來插入中空容置室14內(如第二十_圖所 示),並使其頂面2丨上的圓球凸塞部%完全抵貼封 住針頭座15之流道151(如第:十:圖所示),此時, 該阻隔板20的前側面23及後側面24分別會與中空 容置室14的内壁面之間,將該中空容置室14間隔 形成第一容置室14a與第二容置室i4fc>。 b. 分別將第一液體藥劑R2充填入第一容容置室 ⑷内,以及第二液體藥劑R3充填入第二容容置室 14b内(如第二十三圖所示)。 201215422 C.接著,先將兩活塞塊30的固定# 38分別插入 封蓋板40之兩半圓固定座45的四槽46内(如第十四 圖所示)’並使該兩活塞塊30與封蓋板4〇完成暫時 性之一體組合(如第十五圖所示)。 d.把組合後兩活塞塊30朝向阻隔板2〇的底部面 22,並同步使封蓋& 4〇之長條缺口 44對準阻隔板The center of the strip notch 44 is round, P ....., and 'on the top surface 41 of the two sides thereof, and the two semi-circular fixing seats 45 are convexly protruded, and the two semi-circular fixing seats 45 are The top of the top is inwardly and recessed with a slot 46 for the two piston blocks 3〇 to be inserted at 38, and corresponding to the fixed wing 16 of the injection cylinder 10 10151515, and then convexly disposed. The two fixing posts 47, the outer diameter of the portion 48 is slightly larger than the diameter of the fixing wing; and the top surface 41 of the two fixing holes 161 and the fixing holes 101 of the end plates 16 of the two fixing posts 47 are opposite to each other, and the side edges The top surface 51 and the bottom surface S2 are connected by the side surface 53 to form an integral one. The top surface S1 corresponds to the two bottom surfaces 22 of the blocking panel 2 At the position, two card boring holes 54 are provided for the two hook hooks to be inserted and fixed. Continuing from the twentieth to the thirty-th, the steps of the above-described combination and filling of the liquid medicine of the present invention are as follows: a. First, the top surface 21 of the baffle plate 20 is inserted into the hollow surface toward the bottom surface of the syringe 1 The inside of the accommodating chamber 14 (as shown in FIG. 20), and the ball bulge portion % on the top surface 2 完全 completely abuts against the flow path 151 of the needle holder 15 (eg, the tenth: In this case, the front side 23 and the rear side 24 of the baffle 20 are respectively separated from the inner wall surface of the hollow accommodating chamber 14, and the hollow accommodating chamber 14 is spaced apart to form the first accommodating chamber 14a and the first Two accommodation room i4fc>. b. Filling the first liquid medicament R2 into the first containment chamber (4), respectively, and filling the second liquid medicament R3 into the second containment chamber 14b (as shown in Fig. 23). 201215422 C. Next, the fixing #38 of the two piston blocks 30 is first inserted into the four slots 46 of the two semicircular fixing seats 45 of the cover plate 40 (as shown in FIG. 14) and the two piston blocks 30 are The cover plate 4〇 completes a temporary one-piece combination (as shown in the fifteenth figure). d. The combined two piston blocks 30 are directed toward the bottom surface 22 of the baffle plate 2, and the caps 44 of the caps &

2〇後(如第二十六圖中的假想線部分所示),便可開 始穿套於阻㈣20上,此時再藉由阻隔板20的導 引作用下來繼續推移封蓋板4〇,則該兩活塞塊3〇會 被同步分別塞入注射筒1〇之第—容置室及第二 容置室14b内,當μ 、 ^ 由封蓋板40之兩固定柱47的末端 部48碰觸到注射筒10中固定翼板16之兩固定孔161 時,只要再次用力迫使兩固定柱47的末端部仏通 過固定翼板之兩固定孔161後,即可將封蓋板4〇 完全緊貼固定在并4Μ·# 1Λ 、m 疋仕7王射筒10乙固定翼板16上,同時 也會對第一容置室@ 14a與第二容置室l4b內的第— 液體藥劑R2與笫-油Μ 兴笫一液體藥劑R3達成完全封閉且不 外漏的效果(如第十六圖及第十七圖所示)。 最後再將推進板50之兩卡榫孔54對準阻隔 板 20 底面 22 的兩凸鉤卡榫28(如第二十八圖所 不)’並施力迫使該雨+掩 X兩卡榫孔54卡扣於該兩凸鉤卡榫 201215422 28上後’便能使推進板50與阻隔板20達成緊固連 結成一體(如第三十圖所示),而整個充填封裝組合的 作業即告完成。 - 再如第三十一圖至第三十六圖所示,當要進行 _ 皮下注射時’先以手指握持推進板50並朝背離封蓋 板4〇的方向施力’便可將阻隔板20開始往外拉出(如 第三十一圖所示),此時,阻隔板20的圓球凸塞部 φ 26與針頭座b的流道151形成脱離,使得注射筒 1〇內原來第一容置室14a與第二容置室14b不再是 被阻隔板20阻隔的狀態而消失還原成中空容置室 14’故原充填於第—容置室14&與第二容置室1仆 內的第一液體藥劑R2與第二液體藥劑尺3也隨即產 生相互混合(如第三十二圖所示),當阻隔板20被 拉移碰觸到兩活塞塊30時,該第一液體藥劑R2與 _ 冑—液11藥劑R3也會同步達到完全充分混合成液態 • 注射用藥劑M2 (如第三十三圖所示),待整個阻隔 • 板2〇中半圓凸柱27的凹環槽271卡入活塞塊30的 半圓環凸緣37内時(如第三十四圖所示),該阻隔 板2〇就無法再繼續移!(前述凹環槽271卡入半圓 環凸緣37内的過程中,因半圓凸柱27的倒圓錐部 272具有斜面導引作用,故能快速地通過半圓環凸綠 201215422 37的阻擋並進入活塞塊3〇的下半圓凹槽%內”接 著,將針頭冑5拔除’便可開始進行皮下注射,其 注射方式與現有注射器的操作方式完全相同,仍以 手指施力於推進板50,使阻隔板2〇往注射筒1〇的 頂面11方向推進’ f由阻隔板20中半圓凸柱27的 凹環槽271頂推兩活塞塊3〇的半圓環凸緣37,使得 兩活塞塊30的固定柱38會脫離封蓋板4〇中兩半圓 固定座45的凹槽46(如第三十五圖所示),並同步 與阻隔板20將液態注射用藥齊!l M2往注射針3來輸 送,直到整個液態注射用藥劑M2被全部輸出完畢為 止,即告完成皮下注射之施#(如第三十六圖所 示)。 上述第一液體藥劑R2與第二液體藥劑R3係同 時被充填入第—容置室14a與第二容置室內, 其兩者的藥劑有效期限會是同—日期,故不會發生 有其中- ^已過期但另—個卻仍未過期的現象,因 而得以完纟避免藥劑過期所導致必須丢棄之無謂浪 費,同時也能免除醫療單位在該部分的成本損失, 並提高其未來探用的意願;再者,該第一液體藥劑 R2與第二液體藥劑R3的混合操作過程均在注射筒 10二中土容置室14的内部來進行,除可達成全程無 201215422 菌操作之要求及避免藥劑 射針筒或其他器具來做為 絕不會發生醫護人員被注 於習知藥劑混合的操作方 護性。 被污染外,亦不必借助注 混合藥劑的工具,因此, 射針扎傷之風險,其相較 式’具有更高度安全之防 如第一十七圖至第三十九圖所示,為本發明中 注射筒10的另-實施例,其中,該注射筒10之中 工容置室14由底部面12至頂部面n之間的內壁面 上,更凸設有兩組相對應之兩道凸肋且該兩道 凸肋17之間的間距d5等於阻隔板2〇中前側面23 與後側面24之間的厚度t (如第三十八圖所示),且 藉由該兩道凸肋17的導引作用,將使阻隔板2〇在 推移過程中更具穩定之功效(如第三十九圖所示)。 如第四十圖至第四十二圖所不,為本發明中注 射筒10的又一實施例’其中,該注射筒10之中空 容置室14由底部面12至頂部面π之間的內壁面 上,更向内凹設有相對應之兩道滑轨凹槽18,且該 兩道滑轨凹槽18的槽寬距離d6亦等於阻隔板2〇中 前侧面23與後側面24之間的厚度t (如第四十一圖 所示),由於該兩道滑軌凹槽18具有導引作用,而 使阻隔板20在推移過程中仍具有穩定之功效(如第 201215422 四十二圖所示)。 如第四十三圖至第四十九圖所示,為本發明中 注射筒1〇的再一實施例,係在靠近該注射筒ι〇頂 部面11的側端面13上另凸設有—圈上環座1(H,且 靠近固定翼板16的侧端面13±又凸設有—圈下環 座102,其中,該上環座101的中段部凹設有一圈上 凹環槽103’由上凹環槽103至該上環S 101底端面 之間的外環面設具成渐縮錐面104,另由上凹環槽 103至該上環座101頂端面之間的外環面則設具成— 圈擔止凸緣105,且該播止凸綠105的外徑尺度d7 大於渐縮錐面1〇4的外徑尺度d8 (如第四十五圖所 示),另於該下環座102的外環表面上凹設有—圈下 凹環槽106 ; 而配合該上環座1〇1與下環座1〇2更包括設有 一套筒60,係套置於注射筒1〇側端面13之上環座 ιοί及下環座1〇2外環表面上的中空圓筒體,其總長 度較注射筒10的總長度短,具有—頂部面61、一底 部面62及—側邊面63,該頂部面61設具成封閉面, 該底部面62設具成開口狀,且該頂部面61與底部 面12之間由侧端面13圈圍連接成一體,其中, 該頂部面61中央開設有一穿透孔64,並在接近底部 [S3 201215422 面62位置的內壁面上凸設有一圈凸肋環6 为於該 底部面62上間隔180度的位置處,往側邊面 各開設有一道長條裂縫槽06 ’且該兩長條裂縫槽μ 的槽底又各接設有一張力孔67,而該長條裂縫槽μ 的長度係垂直跨越過凸肋環65,且其槽寬度小於張 力孔67的孔徑(如第四十六圖及第四十七圖所示) 將該套筒60由其底部面62往注射筒1〇的頂部 面11,而穿套於注射筒10的側端面13上後,該套 筒60的凸肋環65會卡扣入下環座1〇2之下凹2槽 1〇6內㈠口第四十八圖所示)’當阻隔板2〇將注射筒 之中空容置室14內的液態注射用藥劑Μ2全部輸 出並完成皮下注射施打後,只要以一隻手握持套筒 6〇,另一隻手握住靠近注射筒1〇之底部面12的位 置處(如第四十八圖所示),再施力將該套筒6〇朝 注射針3方向拉動㈣,並直到套筒⑽纟凸肋環e 卡扣入上環座101之上凹環槽103內時,即可使注 射針3被包覆在套筒60內(如第四十九圖所示), 且因上環座101之播止凸緣1〇5的外徑尺度d7大於 渐縮錐面1〇4的外徑尺度d8,故套筒6〇之凸肋環 65在卡扣入上凹環# i 〇3 0的同肖,也會受到該搶 止凸緣105 :t同步阻播,而不會發生脫離出上環座 [S] 17 201215422 卜而具有防止醫護人員直接碰觸注射針3發生 扎傷意外的功效。 /第五十圖至第五十三圖所示,係本發明中阻 隔板20的另-實施例,其中,Μ阻隔板20的頂部 面21及兩侧邊面25的表面’更包覆有-防止滲漏 之密封! 29(如第五十圖及第五十—圖所示),而具 有更緊密止漏之功效(如第五十二圖及第五十三圖所 示)。 又如第五十四圖至第五十六圖及第十二圖與第 十三圖所示,係本發明之另—實施例,其包括: -注射筒10,係為透明中空圓筒體,具有―頂 部面丨1、一底部面12及一侧端面13,該頂部面U 叹具成封閉面’該底部面12設具成開口⑽,且該頂 部面11肖底部胃12之間由該側端面13圈圍連接成 體’並在內部形成有一中空容置室如第十三 圖所不)’其中’該頂部面η的中央向外凸設有— 十頭座15,並於針頭座15的中央再貫穿有一流道 15 1,且該流道151與中空容置室14相互貫通,另 於底部面12上朝側端面13方向外擴形成有一固定 翼板16’並在該固定翼板16上穿設有相對稱之兩固 定孔161 (如第十二圖所示); 201215422After 2 ( (as shown in the imaginary line part in Fig. 26), it can be put on the damper (4) 20, and then the cover plate 4 继续 is continued by the guiding action of the baffle plate 20, Then, the two piston blocks 3〇 are synchronously inserted into the first accommodating chamber and the second accommodating chamber 14b of the syringe 1〇, respectively, when μ, ^ are the end portions 48 of the two fixing posts 47 of the sealing cover 40 When the two fixing holes 161 of the fixing wing 16 in the syringe 10 are touched, the sealing plate 4 can be completely completed by forcing the end portions of the two fixing posts 47 to pass through the two fixing holes 161 of the fixing blade again. It is fastened to the first liquid container R1 of the first housing chamber @14a and the second housing chamber 14b, and is also fixed on the 4Μ·#1Λ, m 疋仕7王射筒 10 fixed wing plate 16 It achieves a completely closed and non-leakage effect with the 笫-Μ Μ 液体 液体 liquid pharmaceutical agent R (as shown in Figures 16 and 17). Finally, the two latching holes 54 of the pusher plate 50 are aligned with the two hook hooks 28 of the bottom surface 22 of the baffle plate 20 (as shown in FIG. 18) and force the rain to cover the X card. After the 54 clips on the two hook hooks 201215422 28, the pusher plate 50 and the baffle plate 20 can be fastened and integrated (as shown in FIG. 30), and the operation of the entire filling and packaging combination is reported. carry out. - As shown in the 31st to 36th, when the _ subcutaneous injection is to be carried out, 'hold the pusher plate 50 with your finger and apply force in the direction of the back cover 4〇' to block The plate 20 starts to be pulled out (as shown in the thirty-first figure). At this time, the ball joint portion φ 26 of the baffle plate 20 is separated from the flow path 151 of the needle holder b, so that the original portion of the syringe 1 is The first accommodating chamber 14a and the second accommodating chamber 14b are no longer blocked by the barrier plate 20, and are reduced to the hollow accommodating chamber 14'. Therefore, the first accommodating chamber 14a and the second accommodating chamber 14b are filled in the first accommodating chamber 14& and the second accommodating chamber. 1 The first liquid medicament R2 and the second liquid medicament gauge 3 are also mixed with each other (as shown in FIG. 22), and when the barrier 20 is pulled and touched to the two piston blocks 30, the first A liquid medicament R2 and _ 胄-Liquid 11 medicament R3 will also be fully fully mixed into a liquid state • Injectable medicament M2 (as shown in Figure 33), after the entire barrier • Plate 2 〇 medium semicircular stud 27 When the female ring groove 271 is snapped into the semi-circular flange 37 of the piston block 30 (as shown in FIG. 34), the baffle plate 2 can no longer be renewed. Shift! (In the process in which the aforementioned concave ring groove 271 is caught in the semicircular flange 37, since the inverted conical portion 272 of the semicircular projection 27 has a slope guiding effect, it can quickly pass through the blocking of the semicircular green 201215422 37 and Entering the lower semicircular groove % of the piston block 3 ” "then, the needle 胄 5 is removed" can start subcutaneous injection, the injection mode is exactly the same as that of the existing syringe, and the finger is applied to the pusher plate 50, Advancing the baffle plate 2 toward the top surface 11 of the syringe barrel 1 f. Pushing the semi-annular flange 37 of the two piston blocks 3〇 by the concave ring groove 271 of the semicircular stud 27 in the baffle plate 20, so that the two pistons The fixing post 38 of the block 30 will be disengaged from the recess 46 of the two semicircular fixing seats 45 in the cover plate 4 (as shown in the thirty-fifth figure), and the liquid injection can be synchronized with the baffle plate 20! The needle 3 is transported until the entire liquid injection medicament M2 is completely outputted, that is, the subcutaneous injection is performed (as shown in the thirty-sixth diagram). The first liquid medicament R2 and the second liquid medicament R3 are At the same time, it is filled into the first accommodating chamber 14a and the second accommodating chamber, The expiration date of the pharmacy will be the same-date, so there will be no phenomenon in which - ^ has expired but the other has not expired, so that it is possible to avoid unnecessary waste that must be discarded due to overdue of the medicament, and also It can exempt the medical unit from the cost loss in this part and increase its willingness to explore in the future; further, the mixing operation process of the first liquid medicine R2 and the second liquid medicine R3 is in the soil receiving chamber of the syringe 10 The internals of 14 are carried out, except that the requirements of the 201215422 bacteria operation can be achieved and the syringes or other instruments are avoided to be used as the operation protection of the medical personnel to be mixed with the conventional medicines. There is no need to resort to a tool for injecting a mixture of medicaments. Therefore, the risk of needle stick injury is more highly safe than that of the formula 'as shown in Figures 17 to 39, which is an injection in the present invention. In another embodiment of the cartridge 10, wherein the working chamber 14 of the syringe 10 has an inner wall surface between the bottom surface 12 and the top surface n, and two sets of corresponding two ribs are further protruded and The two ribs 17 The spacing d5 is equal to the thickness t between the front side 23 and the rear side 24 of the baffle plate 2 (as shown in the thirty-eighth figure), and by the guiding action of the two ribs 17, the baffle plate will be 2〇 More stable effect during the transition (as shown in Figure 39). As in the fortieth to forty-second figures, another embodiment of the syringe 10 of the present invention is The hollow accommodating chamber 14 of the syringe 10 is provided with an inner wall surface between the bottom surface 12 and the top surface π, and is correspondingly recessed with two corresponding rail grooves 18, and the two rails are concave. The groove width d6 of the groove 18 is also equal to the thickness t between the front side 23 and the rear side 24 of the baffle plate 2 (as shown in FIG. 41), since the two track grooves 18 have a guiding effect. , the barrier plate 20 still has a stable effect during the transition process (as shown in the 201215422 forty-two figure). As shown in the forty-third to forty-ninth, in the embodiment of the present invention, a further embodiment of the syringe 1 is provided on the side end surface 13 adjacent to the top surface 11 of the syringe ι. The ring seat 1 (H, and close to the side end surface 13 of the fixed wing 16 is convexly provided with a ring lower ring seat 102, wherein the middle portion of the upper ring seat 101 is recessed with a ring of upper concave ring groove 103' The outer ring surface between the concave ring groove 103 and the bottom end surface of the upper ring S101 is provided with a tapered tapered surface 104, and the outer annular surface between the upper concave ring groove 103 and the top end surface of the upper ring seat 101 is formed. — a ring-bearing flange 105, and the outer diameter dimension d7 of the abutting convex green 105 is larger than the outer diameter dimension d8 of the tapered tapered surface 1〇4 (as shown in the forty-fifth figure), and the lower ring seat The outer ring surface of the recess 102 is recessed with a concave ring groove 106; and the upper ring seat 1〇1 and the lower ring seat 1〇2 further comprise a sleeve 60, and the sleeve is placed on the side of the side of the injection cylinder 1 The hollow cylindrical body on the outer ring surface of the upper ring ιοί and the lower ring seat 1〇2 has a total length shorter than the total length of the syringe 10, and has a top surface 61, a bottom surface 62 and a side surface 63. The top surface 6 1 is provided with a closed surface, the bottom surface 62 is formed in an open shape, and the top surface 61 and the bottom surface 12 are integrally connected by a side end surface 13 , wherein a through hole is formed in the center of the top surface 61 64, and a ring rib ring 6 is protruded from the inner wall surface close to the bottom portion [S3 201215422 face 62 position] at a position spaced 180 degrees apart from the bottom surface 62, and a long crack groove is opened to each side surface. 06' and the groove bottoms of the two long slit grooves μ are respectively connected with a force hole 67, and the length of the long crack groove μ is perpendicularly spanned over the convex rib ring 65, and the groove width thereof is smaller than the diameter of the tension hole 67. (As shown in the forty-sixth and forty-seventh drawings), the sleeve 60 is passed from the bottom surface 62 thereof to the top surface 11 of the syringe 1 and is placed over the side end surface 13 of the syringe 10. The rib ring 65 of the sleeve 60 will be snapped into the lower ring seat 1 〇 2 under the recess 2 slot 1 〇 6 (a) mouth shown in the forty-eighth figure) 'When the baffle plate 2 〇 will hollow the syringe After the liquid injecting drug solution 2 in the chamber 14 is completely output and the subcutaneous injection is applied, the hand 6 is held by one hand, and the other hand is held by the hand. At the position of the bottom surface 12 of the syringe 1 (as shown in the forty-eighth figure), the force is applied to pull the sleeve 6 〇 toward the injection needle 3 (4), and until the sleeve (10) rib rib ring e card When the inner ring seat 101 is buckled into the concave ring groove 103, the injection needle 3 can be wrapped in the sleeve 60 (as shown in the forty-ninth figure), and the broadcast ring 1 of the upper ring seat 101 is closed. The outer diameter dimension d7 of the crucible 5 is larger than the outer diameter dimension d8 of the tapered conical surface 1〇4, so that the convex rib ring 65 of the sleeve 6〇 is also buckled into the upper concave ring #i 〇3 0 The stagnation flange 105: t is synchronously blocked, and does not break out of the upper ring seat [S] 17 201215422, and has the effect of preventing the medical staff from directly touching the injection needle 3. / Fig. 50 to Fig. 53 are another embodiment of the barrier spacer 20 of the present invention, wherein the top surface 21 of the barrier spacer 20 and the surface of the side faces 25 are further covered with - Prevent leaking seals! 29 (as shown in Figure 50 and Figure 50), with a more tight stop effect (as shown in Figures 52 and 53). Further, as shown in the fifty-fourth to fifty-fifthth and twelfth and thirteenth drawings, another embodiment of the present invention includes: - a syringe 10 which is a transparent hollow cylinder , having a top surface 丨 1, a bottom surface 12 and a side end surface 13 , the top surface U slaps into a closed surface 'the bottom surface 12 is provided with an opening (10), and the top surface 11 is bottomed between the stomach 12 The side end surface 13 is connected to the body and is formed with a hollow accommodation chamber (not shown in FIG. 13). The center of the top surface η is convexly disposed at the center of the top surface η. The center of the seat 15 is further penetrated with a first-class passage 15 1 , and the flow passage 151 and the hollow accommodation chamber 14 are mutually penetrated, and a fixed wing panel 16 ′ is further formed on the bottom surface 12 toward the side end surface 13 and is fixed at the same. The wing plate 16 is provided with two fixing holes 161 (as shown in the twelfth figure); 201215422

阻隔板200,係由三個長條扁平葉片201互呈 120度夾角排列連結而成,其頂面中央向外凸設有— 圓球凸塞部202 ’由該圓球凸塞冑2〇2的圓心作為軸 心,再朝底面方向延伸後分別在三個長條扁平葉片 2〇1之間各凸設有一三分之—圓凸柱2〇3,且該三分 之圓凸柱203上又各凹設有—相對稱之凹環槽 204 ’並在該每—凹環槽2〇4的尾端設具成倒圓錐部 205’另於每-長條扁平葉片2〇1的底面上各凸設有 一凸鉤卡榫206 (如第五十四圖所示); 二活塞塊3 00,為具有相同體積的三個三分之— 圓柱體,#外周,緣面的半徑等於注射冑1〇纟中空容 置室14內緣口徑dl的三分之_,均具有—頂面 301、一底面 302、 ~前側面303及一三分之—圓弧 後側面304,其中,由該頂面3〇1中央往底面3〇2方 向的前側胃303上,凹設有同軸心之上三分之—圓 凹槽305肖下三分之—圓凹槽遍,並在該上三分之 圓凹槽306之間設有一 上三分之一圓凹槽305 一圓凹槽305與下三分之一 三分之一圓環凸綠3 07,使該 與下三分之一圓凹槽3〇6之間形成相互貫通,又該 底面3〇2向外凸設有-固定柱308,JL該固定柱308 靠近底面3 02的上段部外周緣面上,與三分之一圓 201215422 弧後側面304的外周綠面上包覆有一防止滲漏之密 封層309 ; 一封蓋板400,其外觀輪廓與注射筒1〇之固定 • 翼板16相同’具有—頂面401、一底面4〇2及—側 . ㈣4〇3,該商術與底面402之間由該側邊面 4〇3圈圍連接成—體’其中,由頂胃4〇1中央位置朝 底面402貫穿設有互呈12〇度夹角排列的三道長條 • 缺口 4〇4,可供阻隔板200穿過,另以該三道長條缺 口 404中央為圓心,分別在頂面41上再凸設有三個 二分之一圓固定座405,而由該三個三分之—圓固定 座405的頂面向内又各凹設有—凹槽4〇6,可供三活 塞塊3〇0之固定柱308插人,另相對應於注射筒1〇 中固定翼板b之兩固定孔m的頂面4〇1上,再凸 設有兩固定柱407’且該兩固定柱4〇7的末端部伽 • 夕卜徑略大於該固定翼板16之兩固定孔161的孔徑; • 及 卫, 一推進板500,具有一頂面5〇1、一底面5〇2及 -側邊面5〇3,該頂面5〇1與底面5〇2之間由該侧邊 面5〇3圈圍連接成—體,其中,該頂面5〇ι相對應 於阻隔板200底面之三凸鉤切2〇6㈣置處,穿 設有三個卡榫孔5〇4,可供三凸鉤卡榫2〇6插入卡合 [S] 20 201215422 固定之用。 上述本發明另一實施例的組合及充填藥劑等方 式與前述本發明相同’不再贅述,當阻隔板200福 入注射筒10之中空容置室14後(如第五十五圖所 示),該阻隔板200的三個長條扁平葉片2〇1便會將 中空容置室14間隔形成有三個小容置室Mc,而能 &供二種不同液態注射用藥劑M3'M4及M5充填之 用(如第五十六圖所示),除可在注射筒1〇內直接 進行混合三種不同液態注射用藥劑之功能外,亦不 必借助注射針筒或其他器具來做為混合藥劑的工 具,故絕不會發生醫護人員被注射針扎傷之風險,The baffle plate 200 is formed by three elongated flat blades 201 arranged at an angle of 120 degrees with each other, and the center of the top surface of the baffle plate is convexly outwardly - the ball plug portion 202' is formed by the ball plug 胄2〇2 The center of the circle serves as the axis, and then extends toward the bottom surface, and a three-third-circle-convex post 2〇3 is respectively protruded between the three elongated flat blades 2〇1, and the three-point circular stud 203 Further, each of the recesses is provided with a symmetrical groove groove 204' and is provided with an inverted conical portion 205' at the end of each of the concave ring grooves 2〇4 and a bottom surface of each of the long flat blades 2〇1 Each of the convex protrusions is provided with a convex hook 榫 206 (as shown in FIG. 54); the second piston block 3 00 is three three-thirds of the same volume - the cylinder, #外周, the radius of the rim surface is equal to the injection三1〇纟, the third of the inner diameter dl of the hollow accommodation chamber 14 has a top surface 301, a bottom surface 302, a front side surface 303, and a third-corner rear side surface 304, wherein The top surface 3〇1 is centered on the front side stomach 303 in the direction of the bottom surface 3〇2, and the recess is provided with a three-point on the concentricity—the circular groove 305 is three-thirds of the circumference—the circular groove is over, and the upper three points are Between the circular groove 306 is provided a top third circular groove 305, a circular groove 305 and a lower third third ring convex green 3 07, so that the lower third groove 3〇6 is formed to penetrate each other, and the bottom surface 3〇2 is convexly disposed outwardly-fixed post 308, JL is fixed to the outer peripheral surface of the upper portion of the bottom surface 312, and the third circle is 201215422 arc The outer peripheral green surface of the rear side surface 304 is covered with a sealing layer 309 for preventing leakage; a cover plate 400 having the same outline as the fixing of the syringe 1 • the flap 16 has a top surface 401 and a bottom surface 4 〇2 and - side. (4) 4〇3, the business and the bottom surface 402 are connected by the side surface 4〇3 circle into a body body, wherein the central position of the top stomach 4〇1 is penetrated to the bottom surface 402. Three strips arranged at an angle of 12 degrees • No gaps 4〇4 for the baffle 200 to pass through, and the center of the three strips 404 is centered, and three dichotomies are respectively protruded on the top surface 41. One of the three fixing seats 405, and the top of the three-third-circle fixing seat 405 is inwardly recessed and provided with a groove 4〇6 for the solidification of the three-piston block 3〇0 The fixed column 308 is inserted into the top surface 4〇1 of the two fixing holes m of the fixed wing b in the syringe 1 , and the two fixing posts 407 ′ are further protruded and the two fixing posts 4 〇 7 The end portion of the gamma sigma diameter is slightly larger than the aperture of the two fixing holes 161 of the fixed wing plate 16; and a welcoming plate 500 having a top surface 5〇1, a bottom surface 5〇2, and a side surface 5 〇3, the top surface 5〇1 and the bottom surface 5〇2 are connected by the side surface 5〇3, wherein the top surface 5〇 corresponds to the three convex hooks on the bottom surface of the baffle plate 200. Cut 2〇6(4) and place it with three card holes 5〇4 for three-joint hooks 2榫6 to insert and snap [S] 20 201215422 for fixing. The combination of the above-described embodiment of the present invention and the filling of the medicament and the like are the same as those of the foregoing invention, and will not be described again. When the barrier plate 200 is inserted into the hollow accommodation chamber 14 of the syringe 10 (as shown in FIG. The three long flat blades 2〇1 of the baffle plate 200 will form three small accommodating chambers Mc, and can be used for two different liquid injecting medicaments M3'M4 and M5. For filling purposes (as shown in Figure 56), in addition to the function of mixing three different liquid injectable drugs directly in the syringe, it is not necessary to use a syringe or other device as a mixed drug. Tools, so there is no risk that the medical staff will be injured by the injection needle.

其相較於習知藥劑混合的操作方式,仍具有更高度 安全之防護性。 X 【圖式簡單說明】It is still more highly safe and protective than the conventional method of mixing the chemicals. X [Simple description of the diagram]

液之示Liquid indication

樂劑瓶內的作動示意圖。 習知注射Schematic diagram of the action inside the bottle. Conventional injection

的示意围。 [射藥劑 201215422 第七圖:係習知混合液體注射藥劑的作動示意圖之 第八圖:係習知混合液體注射藥劑的作動示意圖之 二 〇 第九圖··係搖晃習知混合液體注射藥劑瓶的示意圖。 第十圖:係習知以注射針筒抽取混合後液態注射藥 劑之示意圖。 第十一圖:係本發明之立體分解圖。 第十二圖 第十三圖 第十四圖 第十五圖 第十六圖 第十七圖 第十八圖 第十九圖 第二十圖 第二十一圖 圖 係第十一圖中1 2-1 2剖面線之剖面圖。 係第十一圖中13-13剖面線之剖面圖。 係本發明中活塞塊的前視圖。 係第十四圖中1 5 -1 5剖面線之剖面圖。 係第十一圖中1 6 - 1 6剖面線之剖面圖。 係第十一圖中1 7-1 7剖面線之剖面圖。 係第十一圖中1 8-1 8剖面線之剖面圖。 係第十一圖中19-19剖面線之剖面圖。 係第十一圖中20-20剖面線之剖面圖。 •係本發明組合及充填液體藥劑的作動 不意圖之一。 •係本發明組合及充填液體藥劑的作動 示意圖之二。 •係本發明組合及充填液體藥劑的作動 示意圖之三。 係本發明組合及充填液體藥劑的作動 不意圖之四。 •係本發明組合及充填液體藥劑的作動 第二 第二十 第二十四圖 第二十五圖 [S] 22 201215422 第 六 第 十七圖: 第 八圖: 第二十九圖: 第三 第三 第三 第三 第三 第三 第三 第三 十圖:係 十一圖 十二圖 十四圖 十五圖 十六圖 十七圖 第三十八圖 第三十九圖 第四十圖: 第四十一圖 第四十二圖 不意圖之五。 係本發明組合及充填液體藥劑的作動 示意圖之六。 係本發明組合及充填液體藥劑的作動 示意圖之七。 係本發明組合及充填液體藥劑的作動 不意圖之八。 係本發明組合及充填液體藥劑完成後 的底視圖。 第二十九圖中30-30剖面線之剖面圖。 係本發明操作使用之作動示意圖之一。 係本發明操作使用之作動示意圖之二。 係本發明操作使用之作動示意圖之三。 係本發明操作使用之作動示意圖之四。 係本發明操作使用之作動示意圖之五。 係本發明操作使用之作動示意圖之六。 :係本發明中注射筒之另一實施例的立 體示意圖。 •係第三十七圖中38-38剖面線之剖面 圖。 係第二十七圖中39-39剖面線之剖面 圖。 係本發明中注射筒之又一實施例的立體 示意圖。 .係第四十圖中4 1 -4 1剖面線之剖面圖。 係第四十圖中42-42剖面線之剖面圖。 m 23 201215422 第四十三圖:係本發明中注射筒之再一實施例的立 體示意圖。 第四十四圖:係第四十三圖中44-44剖面線之剖面 圖。 第四十五圖:係第四十三圖中45-45剖面線之剖面 圖。 - 第四十六圖:係第四十三圖中46-46剖面線之剖面 圖。 第四十七圖:係第四十三圖中47-47剖面線之剖面 φ 圖。 第四十八圖:係本發明中注射筒再一實施例的操作 使用作動示意圖之一。 第四十九圖:係本發明中注射筒再一實施例的操作 使用作動示意圖之二。 第五十圖:係本發明中阻隔板之另一實施例的立體 不意圖。 第五十一圖:係第五十圖中5 1 -5 1剖面線之剖面圖。 第五十二圖:係本發明中阻隔板另一實施例的組合 ^ 剖面示意圖之-。 • 第五十三圖··係本發明中阻隔板另一實施例的組合 . 剖面示意圖之二。 第五十.四圖:本發明另一實施例的立體分解圖。 第五十五圖:本發明另一實施例的局部立體組合圖。 第五十六圖:本發明另一實施例的局部組合示意圖。 【主要元件符號說明】 1、la、lb -注射藥劑瓶 2-瓶口塞 [S1 24 201215422 4、10-注射筒 11 、 21 、 61-頂部面 13-側端面 14a-第一容置室 1 4 c -小容置室 16-固定翼板 1 8 -滑轨凹槽 23 、 33 、 303-前侧面 503-側邊面 27-半圓凸柱 29、39、309-密封層 501- 頂面 502- 底面 36-下半圓凹槽 38、308、407-固定柱 44-長條缺口 46、406-凹槽 48、408-末端部 3-注射針 5-針頭蓋 12 、 22 、 62-底部面 14- 中空容置室 14b-第二容置室 15- 針頭座 17-凸肋The indication of the circumference. [Pharmaceuticals 201215422] Figure 7: The eighth diagram of the schematic diagram of the operation of the conventional mixed liquid injecting agent: The second part of the schematic diagram of the operation of the conventional mixed liquid injecting agent. The shaking figure is a mixed liquid injection pharmaceutical bottle. Schematic diagram. Fig. 10 is a schematic view showing the liquid injection of the mixed liquid after the extraction of the syringe by the injection syringe. Figure 11 is a perspective exploded view of the present invention. Twelfth Figure Thirteenth Figure Fourteenth Figure Fifteenth Figure Sixteenth Figure Seventeenth Figure Eighteenth Figure 19th Figure Twentyth Figure 21st Figure Figure 11 -1 2 section line profile. It is a sectional view of the 13-13 section line in the eleventh figure. A front view of a piston block in the present invention. Figure 14 is a cross-sectional view of the 1 5 -1 5 section line in Figure 14. It is a sectional view of the 1 6 - 16 hatching in the eleventh figure. It is a sectional view of the 1 7-1 7 section line in the eleventh figure. It is a sectional view of the 1 8-1 8 section line in the eleventh figure. It is a sectional view of the 19-19 section line in the eleventh figure. A section of the 20-20 section line in Figure 11. • One of the intents of the combination of the present invention and the filling of a liquid medicament. • A schematic diagram of the combination of the invention and the action of filling a liquid medicament. • A third schematic diagram of the combination of the present invention and the action of filling a liquid medicament. The combination of the present invention and the action of filling a liquid medicament is not intended to be four. • Actuation of the combination of the invention and filling of a liquid medicament. Second twentieth twenty-fourth twenty-fifth diagram [S] 22 201215422 sixth seventeenth diagram: eighth diagram: twenty-ninth diagram: third Third, third, third, third, third, thirtyth: system, eleven, twelve, fourteen, fifteen, sixteen, sixteen, seventeen, thirty-eighth, thirty-ninth, forty-fifth : Forty-first picture, forty-second picture, is not intended. It is a schematic diagram of the combination of the present invention and the operation of filling a liquid medicament. It is a schematic diagram of the combination of the present invention and the operation of filling a liquid medicament. The combination of the present invention and the action of filling a liquid medicament is not intended. A bottom view of the combination of the invention and the completion of filling of the liquid medicament. A section of the 30-30 section line in the twenty-ninth figure. It is one of the actuation diagrams used in the operation of the present invention. It is the second schematic diagram of the operation used in the operation of the present invention. It is the third schematic diagram of the operation used in the operation of the present invention. It is the fourth schematic diagram of the operation used in the operation of the present invention. It is the fifth schematic diagram of the operation used in the operation of the present invention. It is the sixth schematic diagram of the operation used in the operation of the present invention. : A schematic view of another embodiment of a syringe of the present invention. • A section of the 38-38 section line in Figure 37. It is a sectional view of the 39-39 section line in the twenty-seventh figure. A perspective view of yet another embodiment of a syringe of the present invention. A cross-sectional view of the 4 1 - 4 1 section line in the fortieth figure. A section of the 42-42 section line in the fortieth figure. m 23 201215422 FIG. 43 is a schematic view showing still another embodiment of the syringe of the present invention. Figure 44: A section of the 44-44 section line in the 43rd picture. Figure 45: A section of the 45-45 section line in the 43rd picture. - Figure 46: Sectional view of the 46-46 section line in the 43rd picture. Figure 47: The section φ of the 47-47 section line in the 43rd picture. Fig. 48 is a view showing the operation of still another embodiment of the syringe of the present invention. Forty-ninth Figure: The operation of the syringe of the present invention is the second embodiment of the operation. Fig. 50 is a perspective view of another embodiment of the barrier spacer of the present invention. Figure 51: Sectional view of the 5 1 -5 1 section line in Figure 50. Figure 52 is a cross-sectional view of another embodiment of the barrier layer of the present invention. • Fig. 53 is a combination of another embodiment of the barrier plate of the present invention. Fig. 50 is a perspective exploded view of another embodiment of the present invention. Figure 55 is a partial perspective assembled view of another embodiment of the present invention. Figure 56 is a partial assembly diagram of another embodiment of the present invention. [Description of main component symbols] 1. la, lb - injection bottle 2-bottle stopper [S1 24 201215422 4, 10-injection cylinder 11, 21, 61-top surface 13-side end surface 14a-first accommodation chamber 1 4 c - small accommodation chamber 16 - fixed wing 1 8 - rail groove 23, 33, 303 - front side 503 - side surface 27 - semicircular projection 29, 39, 309 - sealing layer 501 - top surface 502 - bottom surface 36 - lower semicircular recess 38, 308, 407 - fixing post 44 - strip notch 46, 406 - recess 48, 408 - end portion 3 - injection needle 5 - needle cover 12, 22, 62 - bottom surface 14 - Hollow accommodation chamber 14b - second accommodation chamber 15 - needle holder 17 - rib

20、200-阻隔板 24-後側面 25 、 43 、 53 、 63 、 403 、 26、202-圓球凸塞部 28、206-凸鉤卡榫 30、300-活塞塊 31 、 41 、 51 、 301 、 401 、 32 、 42 、 52 、 302 、 402 、 34- 半圓弧後侧面 35- 上半圓凹槽 37-半圓環凸緣 40、400-封蓋板 45-半圓固定座 47-固定柱 50、500-推進板 54、504-卡榫孔 [S3 25 201215422 60-套筒 65-凸肋環 67-張力孔 102-下環座 104-渐縮錐面 106-下凹環槽 1 6 1 -固定孔 6 4 -穿透孔 66-長條裂縫槽 1 0 1 -上環座 103-上凹環槽 105-擋止凸緣 1 5 1 -流道 201-三個長條扁平葉片 203-三分之一圓凸柱 271、2 04-凹環槽 272、205-倒圓錐部 304-三分之一圓弧後侧面 305-上三分之一圓凹槽 306-下三分之一圓凹槽 307-三分之一圓環凸緣 404-三道長條缺口 405-三分之一圓固定座 dl-內緣口徑 d2、d5-間距 d3、d4-距離長度 d6-槽寬距離 d7、d8-外徑尺度 G-坡璃瓶20, 200 - baffle plate 24 - rear side 25, 43, 53, 63, 403, 26, 202 - ball plug portion 28, 206 - hook hook 30, 300 - piston block 31, 41, 51, 301 , 401 , 32 , 42 , 52 , 302 , 402 , 34- semicircular arc rear side 35 - upper semicircular recess 37 - semicircular flange 40, 400 - cover plate 45 - semicircular mount 47 - fixed post 50 , 500-propulsion plate 54, 504 - card hole [S3 25 201215422 60-sleeve 65 - rib ring 67 - tension hole 102 - lower ring seat 104 - tapered cone surface 106 - concave ring groove 1 6 1 - Fixing hole 6 4 - penetrating hole 66 - strip crack groove 1 0 1 - upper ring seat 103 - upper ring groove 105 - blocking flange 1 5 1 - flow path 201 - three long flat blades 203 - three points One of the rounded studs 271, 024 - the concave ring groove 272, 205 - the inverted conical section 304 - the third arc of the rear side 305 - the upper third of the circular groove 306 - the lower third of the circular groove 307-third ring flange 404-three strips notch 405-third circle seat dl-inner edge diameter d2, d5-spacing d3, d4-distance length d6-slot width distance d7, d8- Outer diameter scale G-slope bottle

Ml、M2、M3、M4、M5-液態注射用藥劑 R-液態處方藥劑 R1-藥劑溶液 R2-第一液體藥劑 R3-第二液體藥劑 rl、r2、r3、r4 -半徑 S-粉末狀 Leuprorelin acetate 藥劑 t-厚度 [S] 26Ml, M2, M3, M4, M5-liquid injection medicament R-liquid prescription medicament R1-pharmaceutical solution R2-first liquid medicament R3-second liquid medicament rl, r2, r3, r4 - radius S-powdered Leuprorelin acetate Pharmacy t-thickness [S] 26

Claims (1)

201215422 七、申請專利範圍: 丨.-種:可容置不同注射藥劑之注射器」,係包括: -注射筒’為透明中空圓筒體’具有 —底部面及一側锉高、 、司面、 可四及㈣%面’該頂部面設具 部面設具成開口狀 ’該底 兴现開口狀,且該頂部面與底部 端面圈圍連接成__!! 該側 — 接成體,並在內部形成有-中空容置 其中,該頂部面的中央向外凸設有— 时央再貫穿有—流道流道與中空容 至相互貫通,另於底部上朝 關,面万向外擴形成 有—固定翼板,並在該固 队 固定孔; ㈣疋翼板上穿設有相對稱之兩 平長條體’具有一頂部面 阻隔板,係塞置入注射筒之中空容置室内的扁 底部面、一前側面、後 側面及相互平行之兩側邊面’該兩側邊面之間的間距 與注射筒之中空容置室的內緣口徑相等,但該頂部面 與底部面之間的距離長度則大於注射筒之頂部面與 底部面之間的距離長度’其中,該頂部面 設有-圓球凸塞部’由該圓球凸塞部的圓心作為軸 心’再朝底部面方向延伸後分別在前侧面與後侧面上 各凸設有一半圓凸柱,且該兩半圓凸柱上又各凹設有 -相對稱之凹環槽’並在該每一凹環槽的尾端設具成 倒圓錐部’另冑底部面上凸設有兩對稱之凸鉤卡榫; 27 201215422201215422 VII. Scope of application for patents: 丨.- Kind: syringes that can accommodate different injections of drugs", including: - The syringe "is a transparent hollow cylinder" with a bottom surface and a side height, a surface, Four sides and (four)% of the surface of the top surface of the upper surface of the device is provided with an opening shape. The bottom surface is open and the bottom surface is connected with the bottom end surface to form a __!! Formed in the interior - hollow accommodation, the center of the top surface is convex outwardly - the center is then penetrated - the flow channel and the hollow space are connected to each other, and the bottom is closed to the outside. Forming a fixed wing plate and fixing the hole in the fixed team; (4) wearing a symmetrical symmetrical strip body on the flap plate having a top surface resisting partition, and the plug is placed in the hollow receiving room of the injection cylinder The flat bottom surface, the front side surface, the rear side surface, and the mutually parallel side surfaces 'the spacing between the two side surfaces is equal to the inner diameter of the hollow housing chamber of the syringe, but the top surface and the bottom surface The distance between the length is greater than the top surface of the syringe The distance between the bottom faces is 'the middle face is provided with a - ball plug portion' from the center of the ball plug portion as the axis center and then extends toward the bottom face surface on the front side and the back side, respectively Each of the convex protrusions is provided with a semi-circular protrusion, and the two semi-circular protrusions are respectively recessed with a symmetrical socket groove and are provided with an inverted conical portion at the end of each concave ring groove. Two convex hooks are provided on the upper convex; 27 201215422 兩活塞塊,為具有相同體積的兩個半圓柱體,其 外周緣面的半徑等於注射筒之中空容置室內緣口徑 的一分之一,具有—頂面、一底面、一前側面及一半 圓弧後側面’由該頂面中央往底面方向的前側面上, 凹设有同軸心之上半圓凹槽與下半圓凹槽,並在該上 半圓凹槽與下半圓凹槽之間設有一半圓環凸緣,使該 上半圓凹槽與下半圓凹槽之間形成相互貫通,又該底 面向外凸設有—固定柱,且該固定柱靠近底面的上段 部外周緣面上’與半圓弧後側面的外周緣面上包覆有 、防止滲漏之密封層,其中,該上半圓凹槽的半徑與 該阻隔板之半圓凸柱的半徑相等,該半II環凸緣的半 徑與該半圓凸柱之凹環槽的半徑相等; 一封蓋板,其外觀輪廓與注射筒之固定翼板相 同’具有—頂面、—底面及—側邊面,該頂面與底面 之間由該側邊面圈圍連接成—體,其巾,由頂面中央 位置朝底面貫穿設有—長條缺口,並以該長條缺口中 央為圓〜、’分別在其兩側位置的頂面上,肖凸設有相 封稱的兩半圓固定座,另由該兩半圓固定座的頂面向 內又各凹設有-凹槽,而相對應於注射筒中固定翼板 i兩固定孔的頂面上,再凸設有兩㈣柱;及 —推進板,具有—頂 頂面與底面之間由該側邊 面、—底面及一側邊面’該 面圈圍連接成一體,其中, [SI 28 201215422 該頂面相對應於阻隔板中底部面之兩㈣卡榫的位 置處’穿設有兩卡榫孔。 2,如申請專利範圍第!項所述之「可容 之注射器」,其中,該注射n 主射藥劑 至頂部面之間的内壁面上,再凸 由底部面 ^ ϋ 8又有兩組相對庵+ m 道凸肋,且該兩道凸肋之間的間距等於阻 ^ 面與後侧面之間的厚度。 、 反中前側 3.如申請專利範圍第〗項所述之「可容 之注射器」,其中,該注射 U·/王射樂劑 丁 βν 王射筒之中空容置室 至頂部面之間的內壁面上,至由底部面 道滑軌凹槽,且今雨m有相對應之兩 槽·^兩道滑軌凹槽的槽寬距離等於阳戸 板中前侧面與後侧面之間的厚度。 等於阻隔 4.如申請專利範圍第!項所述 述i可容置不同注射藥劑 7射器」,其中,該阻隔板的 W讽07 !貝邵面及兩側邊面 表面,更包覆有-防止渗漏之密封層。 可容置不同注射藥劑之注射器」,係包括 種 -注射筒,為透明中空圓筒體,具有—頂部面、 —底部面及—側端面,該頂部面設具成封閉面,該底 部面設具成開口狀,且哼頂鈾 W且碎頂部面與底部面之間由該侧 知面圈圍連接成—體,並在內部形成有—中 «胃W設有—針職,並 座的中央再貫穿;η 再貫穿有一也道,且該流道與中空容置室相 互貫通,另於底部面上朝側端面方向外擴形成有—固 S3: 29 201215422 定翼板’並在該固定翼板上穿設有相對稱之兩固定 孔’其中,該注射筒在靠近頂部面的侧端面上另凸設 有一圈上環座’並於靠近固定翼板的側端面上再凸設 有一圈下環座’另該上環座的中段部再凹設有一圈上 凹環槽’且由該上凹環槽至該上環座底端面之間的外 環表面設具成渐縮錐面,而由該上凹環槽至該上環座 頂端面之間的外環表面則設具成一圈擋止凸緣,且該 擋止凸緣的外徑尺度大於該渐縮錐面的外徑尺度,又 於該下環座的外環表面上凹設有一圈下凹環槽; —阻隔板,係塞置入注射筒之中空容置室內的扁 平長條體,具有一頂部面、 一底部面、一前侧面、後 側面及相互平行之兩侧邊面,該兩側邊面之間的間距 口徑相等’但該頂部面The two piston blocks are two semi-cylindrical bodies having the same volume, and the outer peripheral surface has a radius equal to one-half of the diameter of the hollow housing inner edge of the syringe, and has a top surface, a bottom surface, a front side surface and a half The rear side of the circular arc is provided with a semicircular groove and a lower semicircular groove on the concentric side from the center of the top surface toward the bottom surface, and is disposed between the upper semicircular groove and the lower semicircular groove. a half ring flange, such that the upper semicircular groove and the lower semicircular groove form a mutual penetration, and the bottom surface is convexly provided with a fixing column, and the fixing column is close to the outer peripheral surface of the upper portion of the bottom surface' The outer peripheral surface of the rear side of the semicircular arc is covered with a sealing layer for preventing leakage, wherein the radius of the upper semicircular groove is equal to the radius of the semicircular stud of the baffle, and the radius of the semi-II ring flange The radius of the concave ring groove of the semicircular stud is equal; a cover plate having the same contour as the fixed wing of the syringe has a top surface, a bottom surface and a side surface, between the top surface and the bottom surface Connected by the side ring to form a body, the towel, The central portion of the top surface is provided with a long strip-shaped opening toward the bottom surface, and the center of the strip is rounded, and the top surface of each of the two sides of the strip is provided with a so-called two semi-circular fixing seat. Further, the top surface of the two semi-circular fixing seats is inwardly recessed with a groove, and corresponding to the top surface of the two fixing holes of the fixing wing plate i in the injection cylinder, and then two (four) columns are convexly arranged; and the pushing plate Between the top surface and the bottom surface, the side surface, the bottom surface and the one side surface are integrally connected, wherein [SI 28 201215422 the top surface corresponds to the bottom surface of the barrier plate (4) The position of the cassette is 'with two card holes. 2, such as the scope of patent application! The "capable syringe" as described in the item, wherein the injection of the main injection agent to the inner wall surface between the top faces is further convex from the bottom surface ^ 8 and two sets of opposite 庵 + m ribs, and The spacing between the two ribs is equal to the thickness between the resist and the back side. The anti-middle anterior side 3. As described in the scope of the patent application, the "capable syringe", wherein the injection of the U·/王射乐剂丁βν王筒 of the hollow accommodation chamber to the top surface On the inner wall surface, to the bottom surface of the slide rail groove, and the current rain m has a corresponding groove. The groove width of the two rail grooves is equal to the thickness between the front side and the rear side of the male and female plates. Equal to the barrier 4. As claimed in the patent scope! The i can accommodate different injection injectors, wherein the barrier layer is covered with a sealing layer that prevents leakage. A syringe capable of accommodating different injection medicaments, comprising a seed-injection cylinder, which is a transparent hollow cylinder having a top surface, a bottom surface and a side end surface, the top surface being provided with a closed surface, the bottom surface being provided The utility model has an open shape, and the top uranium W and the top surface and the bottom surface of the crest are connected by the side surface to form a body, and the inside is formed with a middle - stomach The center is further penetrated; η is further penetrated through a road, and the flow path and the hollow accommodation chamber are mutually penetrated, and the bottom surface is expanded outward toward the side end surface to form a solid-shaped S3: 29 201215422 fixed wing plate 'and fixed at the same The wing plate is provided with two opposite fixing holes ′, wherein the injection cylinder has a ring upper ring seat on the side end surface near the top surface and a convex ring is arranged on the side end surface near the fixed wing plate. The ring seat 'the middle portion of the upper ring seat is further recessed with a ring of concave ring groove' and the outer ring surface between the upper concave ring groove and the bottom end surface of the upper ring seat is provided with a tapered cone surface, and The outer ring surface between the upper concave ring groove and the top end surface of the upper ring seat Having a ring-stop flange, and the outer diameter dimension of the stop flange is larger than the outer diameter dimension of the tapered cone surface, and a ring-shaped concave ring groove is recessed on the outer ring surface of the lower ring seat; a baffle plate, the flat strip body placed in the hollow receiving chamber of the syringe, having a top surface, a bottom surface, a front side surface, a rear side surface and two side surfaces parallel to each other, the side surfaces of the two sides The spacing between the holes is equal 'but the top surface 與注射筒之中空容置室的内緣口徑相等 與底部面之間的距離長度則大於注射筒 30 201215422 的 具有一頂面、—底面、一前侧面及一半 圓弧後側面’由該頂面中央往底面方向的前侧面上, 汉有同軸v之上半圓凹槽與下半圓凹槽,並在該上 半圓凹槽與下半圓凹槽之間設有—半圓環凸緣,使該 上半圓凹槽與下半阊 圓凹槽之間形成相互貫通,又該底 面向外凸設有—|ϊ| φ. IV „、、 fe’且該固定柱靠近底面的上段 部外周緣面上,與半圓弧後侧面的外周緣面上包覆有 —防止滲漏之密封層’其中,該上半圓凹槽的半徑與 該阻隔板 > 车® Λ从& 1 ^ 、半徑相等’該半圓環凸緣的半 與孩半圓凸柱之四環槽的半徑相等; 同,:有封蓋:’其外觀輪廊與注射筒之固定翼板相 二頂面、—底面及-側邊面,該頂面與底面 之間由該惻遭面圈圍連接成-體,其中,由頂… 央j面貫穿設有-長條缺口,並以該長條缺口中 央為圓心,分別在其兩側位置的 對稱的兩半圓固定座,另由^設有相 卿U疋湮,另由該兩半圓固定 内又各凹設有—叫而相對應 、; 推進板’具有一頂面 之兩固定孔的頂面上,再凸設有兩固定:;闺疋翼板 底面及~側邊面,該 頂面輿鹿而u 〜遭面’該 、面足間由該側邊面圈圍連接成一 該頂面相對應於阻隔祐φ鹿加 體,其中, 、於阻隔板中底部面之兩 置處,穿設有兩卡榫孔;及 "榫的位 31 IS1 201215422 套筒,係套置於注射筒側端面之上環座及下環 座外環表面上的中空圓筒體,其總長度較注射筒的總 長度短,具有-頂部面、—底部面及—側邊面,該頂 部面议具成封閉面,該底部面設具成開口狀,且該頂 部面與底部面之間由該側端面圈圍連接成一體,其 中該頂部面中央開設有—穿透孔,並在接近底部面 位置的內壁面上凸設有一圈凸肋環’另於該底部面上 間隔1 80度的位置處,往侧邊面上各開設有—道長條 裂縫槽,且該兩長條裂縫槽的槽底又各接設有一張力 孔’而該長條裂縫槽的長度係垂直跨越過凸肋環,且 其槽寬度小於張力孔的孔徑。 6.如申請專利範圍第5項所述之「可容置不同注射藥劑 之注射器」’其中,該注射筒之中空容置室由底部面 至頂部面之間的內壁面上,再凸設有兩組相對應之兩 道凸肋’且該兩道凸肋之間的間距等於阻隔板中前侧 面與後側面之間的厚度。。 7 _如申請專利範圍第5項所述之「可容置不同注射藥劑 之注射器」,其中’該注射筒之中空容置室由底部面 至頂部面之間的內壁面上,又向內凹設有相對應之兩 道滑轨凹槽,且該兩道滑轨凹槽的槽寬距離等於阻隔 板中前側面與後側面之間的厚度。 8.如申請專利範圍第5項所述之「可容置不同注射藥劑 之注射器」,其中,該阻隔板的頂部面及兩側邊面的 [S3 32 201215422 表面’更包覆有一防止滲漏之密封層。 9.—種「可容置不同注射藥劑之注射器」,係包括. —注射筒,為透明中空圓筒體,具有一頂部面、 一底部面及一側端面,該頂部面設具成封閉面’該底 部面設具成開口狀,且該頂部面與底部面之間由該側 端面圈圍連接成一體,並在內部形成有—中空^置 室,其中’該頂部面的中央向外凸設有—針頭座,並 於針頭Μ的中央再貫穿有—流道,且該流道與中空容 置室相互貫通,另於底部面上朝側端面方向外擴形成 有-固定翼板’並在該固定翼板上穿設有相對稱之兩 固定孔; —阻隔板,係由三個長條扁平葉片互呈12〇度夾 角排列連結而成,其頂面中央向外凸設有—圓球凸塞 部,由該圓球凸塞部的圓心作為軸心,再朝底面方向 延伸後分別在三個長條扁平葉片之間各凸設有一三 分乙-圓凸柱’且該三分之_圓凸柱上又各凹設有一 相對稱之凹環槽,並在該盔— 仕碎母凹環槽的尾端設具成倒 圓錐部,另於該每—長倏扁平 贲絛扁平葉片的底面上又各凸設 有一凸鉤卡榫; 三活塞塊,為具有相同體積的三個三分之—圓柱 體’其外周緣面的半徑笔於、汰私 干倥等於注射筒之中空容置室内緣 口徑的二分之一,均|右一 TS 叼具有一頂面、一底面、一前侧面 [SI 33 201215422 及-三分之-圓弧後側面,其中,由該頂面中央往底 面方向的前側面上’凹設有同軸心之上三分之—圓凹 槽與下三分之一圓凹槽 一 u僧,並在該上二分之一圓凹槽與 .τ三分之—圓凹槽之間設有一三分之—圓環凸綠,使 •該上二分之—圓凹槽與下三分之-圓凹槽之間形成 相互貫通’又該底面向 ω ^ 、 u外凸日又有一固定柱,且該固定 柱靠近底面的上段部外固 外周緣面上,與二分之一圓弧後 側面的外周緣面上均句 _ ,.. • 巧包覆有一防止滲漏之密封層; 一 、板其外觀輪廓與注射筒之固定翼板相 同,具有一頂面、—底面及 低面及一側邊面,該頂面與底面 之間由該侧邊面圈圍連接 其中,由頂面中央 仏置朝底面貫穿設有互穿 ..^ 12〇度夾角排列的三道長 “ 广-道長條缺口中央為圓心,分別在頂 面上再凸設有三個三分之一 、 n圓固疋座,且該三個三分 •之一圓固定座的頂面向内 庵於、士^ …乂谷又有-凹槽,另相對 愿於注射筒中}k= μ .… 兩固定孔的頂面上,再凸設 有兩固定柱,且該兩固定柱的末 中留木%部外徑略大於該固 疋翼板z兩固定孔的孔徑;及 底面及一側邊面,該 推進板’具有一頂面 71 Τ5Γ坩θ Η久—W逻囬,該 、 底面之間由該侧邊面圈圍連 ^ m w ^ m 国圓運接成一體,其中, p頂面相對應於阻隔板底面 虚,空呀+― < —凸錦卡禕的位置 處穿設有二個卡榫孔。 m 34The inner diameter of the hollow accommodating chamber of the syringe is equal to the diameter of the bottom surface and the length of the bottom surface is greater than that of the syringe 30 201215422 having a top surface, a bottom surface, a front side surface and a half arc rear side 'by the top surface On the front side of the center toward the bottom surface, there is a semi-circular groove and a lower semi-circular groove on the coaxial v, and a semi-circular flange is provided between the upper semi-circular groove and the lower semi-circular groove, so that the upper side The semicircular groove and the lower semicircular groove form a mutual penetration, and the bottom surface is convexly outwardly provided with -|ϊ| φ. IV „, , fe′ and the fixing column is close to the outer peripheral surface of the upper section of the bottom surface, The outer peripheral surface of the rear side of the semicircular arc is covered with a sealing layer for preventing leakage, wherein the radius of the upper semicircular groove is equal to the resistance of the baffle plate & 1 ^, radius The half of the semi-circular flange is equal to the radius of the four-ring groove of the child's semi-circular stud; the same: there is a cover: 'the outer vertex and the fixed wing of the syringe are two top surfaces, the bottom surface and the side side a surface, the top surface and the bottom surface are connected by a doughnut to form a body, wherein From the top... The central j-plane is provided with a long strip, and the center of the strip is centered on the center of the strip, and the two semicircular fixed seats are located on both sides of the strip, and the other is provided with a pair of U. The two semi-circular fixings are respectively fixed in the recesses, and correspondingly; the propulsion plate has a top surface of two fixing holes on the top surface, and then two fixings are fixed: the bottom surface and the side of the flap The top surface, the top elk and the u ~ the surface 'the, the foot is connected by the side ring to form a top surface corresponding to the barrier φ deer addition body, wherein, in the bottom surface of the barrier Two places, wearing two card boring holes; and "榫 position 31 IS1 201215422 sleeve, the sleeve is placed on the side of the side of the syringe and the hollow cylinder on the outer ring surface of the lower ring seat, The total length is shorter than the total length of the syringe, having a top surface, a bottom surface, and a side surface, the top surface having a closed surface, the bottom surface being provided with an opening shape, and between the top surface and the bottom surface The side end ring is connected to be integrated, wherein the top surface is provided with a through hole at the center. a ring of rib ring is protruded from the inner wall surface near the bottom surface position, and the bottom surface is spaced apart by 180 degrees, and the long side crack groove is opened on each side surface, and the two strips are The groove bottom of the crack groove is further connected with a force hole ', and the length of the long crack groove is perpendicular to the rib ring, and the groove width is smaller than the diameter of the tension hole. 6. As described in claim 5 "Syringe for accommodating different injections"", wherein the hollow accommodation chamber of the syringe has an inner wall surface between the bottom surface and the top surface, and two sets of corresponding two ribs are protruded and The spacing between the two ribs is equal to the thickness between the front side and the back side of the baffle. . 7 _ "Syringe for accommodating different injections" as described in item 5 of the patent application, wherein the hollow accommodation chamber of the syringe is recessed from the bottom surface to the inner surface between the top surfaces Corresponding two rail grooves are provided, and the groove widths of the two rail grooves are equal to the thickness between the front side and the rear side of the baffle. 8. The "Syringe for accommodating different injections" as described in the fifth paragraph of the patent application, wherein the [S3 32 201215422 surface" of the top surface and the side surfaces of the barrier plate is further covered with a leak prevention Sealing layer. 9. A "syringe capable of accommodating different injections", comprising: a syringe, which is a transparent hollow cylinder having a top surface, a bottom surface and a side end surface, the top surface being provided with a closed surface The bottom surface is provided in an open shape, and the top surface and the bottom surface are integrally connected by the side end surface, and a hollow chamber is formed therein, wherein the center of the top surface is convex outward a needle holder is disposed, and a flow passage is further penetrated in the center of the needle cymbal, and the flow passage and the hollow accommodating chamber are mutually penetrated, and the bottom surface is outwardly expanded toward the side end surface to form a fixed wing plate and The fixed wing plate is provided with two fixing holes symmetrical; the baffle plate is formed by three long flat blades which are arranged at an angle of 12 degrees, and the center of the top surface is convex outwardly. a ball plug portion, the center of the ball plug portion is used as an axis, and then extending toward the bottom surface, respectively, a three-branch-circle stud is respectively protruded between the three elongated flat blades, and the three The _ circumstitudinal column is further provided with a symmetrical groove groove, and The inverted end of the helmet-shaped female concave ring groove is provided with an inverted conical portion, and the bottom surface of the flattened flat blade of each of the long clams is further provided with a convex hook card; the three piston block is The three-third-cylindrical body with the same volume has a radius of the outer peripheral surface of the outer circumference of the cylinder, which is equal to one-half of the diameter of the hollow housing of the syringe, and the right one has a Top surface, one bottom surface, one front side [SI 33 201215422 and - three-point - arc rear side, wherein the front side from the center of the top surface to the bottom surface is recessed with a three-point concentricity - The circular groove and the lower third circular groove are u僧, and a three-third-ring convex green is arranged between the upper one-half circular groove and the .τ three-point circular groove. , the upper two-point circular groove and the lower three-point circular groove form a mutual penetration 'the bottom surface of the ω ^, u convex day has a fixed column, and the fixed column is close to the upper part of the bottom surface The outer peripheral surface of the outer solid and the outer peripheral surface of the rear side of the one-half arc are _ ,.. • a sealing layer for preventing leakage; 1. The outer contour of the plate is the same as that of the fixed wing of the syringe, and has a top surface, a bottom surface and a low surface and a side surface, the side surface being separated from the bottom surface by the side surface The dough ring is connected to it, and the center of the top surface is placed to the bottom surface to be interpenetrated.. ^ 12 lengths of the angle of the 12-degree angle. The center of the wide-gauge strip is the center of the circle, and three protrusions are respectively arranged on the top surface. One-third, n-round solid seat, and the top of the three-pointed one-piece fixed seat is inwardly facing, the shi... the valley has a groove, and the other is opposite to the syringe}k= μ .... on the top surface of the two fixing holes, two fixing columns are further convex, and the outer diameter of the left portion of the two fixing columns is slightly larger than the diameter of the two fixing holes of the fixing blade z; and the bottom surface and one In the side surface, the propulsion plate has a top surface 71 Τ 5 Γ坩 θ Η — — W — — — W W W W , , , , , , , W W W W W W W , , , , , , , , , , , , , , , , , , , The top surface corresponds to the bottom of the baffle plate, and the space is empty. + " < - the position of the convex brocade is worn with two Tenon hole. m 34
TW99135408A 2010-10-15 2010-10-15 Syringe capable of containing different injectable medicines TW201215422A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW99135408A TW201215422A (en) 2010-10-15 2010-10-15 Syringe capable of containing different injectable medicines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW99135408A TW201215422A (en) 2010-10-15 2010-10-15 Syringe capable of containing different injectable medicines

Publications (1)

Publication Number Publication Date
TW201215422A true TW201215422A (en) 2012-04-16

Family

ID=46786761

Family Applications (1)

Application Number Title Priority Date Filing Date
TW99135408A TW201215422A (en) 2010-10-15 2010-10-15 Syringe capable of containing different injectable medicines

Country Status (1)

Country Link
TW (1) TW201215422A (en)

Similar Documents

Publication Publication Date Title
JP7174124B2 (en) syringe adapter with cap
US9345642B2 (en) Vial adapter for a needle-free syringe
JP5680414B2 (en) Liquid drug delivery device for use with a syringe having an enlarged tip
RU2440831C2 (en) Devices, systems and methods of liquid introduction
CA2923171C (en) Single-use device for injection of cartridge drugs
US20210128835A1 (en) Systems and methods for pre-filled dual-chamber medical agent delivery
EP3810230A1 (en) Systems and methods for dual-component drug agent delivery
JP2011136153A (en) Kit with syringe assembly
CA2779206C (en) Syringe-carpule assembly
US20120040320A1 (en) Injection Simulation Device and Methods Thereof
JP2018519116A (en) Single-use delivery device pre-filled with reconfigurable medicine
TW201110959A (en) Container capable of accommodating different injection medicinen
US9802002B2 (en) Training cartridge for a drug delivery device
JP2023052685A (en) Mixing vial
JP2022171893A (en) syringe adapter
JP6301944B2 (en) Multi-dose medical container adapter
JP2013536030A (en) Package for delivering drug microdoses
US9833572B2 (en) Modular dual chamber syringe system
KR101504484B1 (en) Filter assembly for syringe
JP2018520776A (en) Single use delivery device with safety features
TW201215422A (en) Syringe capable of containing different injectable medicines
KR20190102176A (en) Container stopper operated by rotation
JP2019520939A (en) Safe drug delivery system
CN102028619B (en) Can the container of accommodating different injection medicament
JP6360036B2 (en) Medicine bottle dosing system and method